Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
about
Selection and characterization of high affinity VEGFR1 antibodies from a novel human binary code scFv phage library.Effects of the vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor SU5416 on in vitro cultures of Plasmodium falciparum.Vascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db miceModulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1.Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant {beta}-Catenin Activation in Colon CancerPreparing the "soil": the premetastatic niche.A Functional Role for VEGFR1 Expressed in Peripheral Sensory Neurons in Cancer PainIdentification of a novel peptide that blocks basic fibroblast growth factor-mediated cell proliferation.Therapeutic effects of fenofibrate on diabetic peripheral neuropathy by improving endothelial and neural survival in db/db miceTargeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy.Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylationConversion of low-affinity peptides to high-affinity peptide binders by using a β-hairpin scaffold-assisted approach.VEGFR-1 mediates endothelial differentiation and formation of blood vessels in a murine model of infantile hemangioma.Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer modelsDecreased efficacy of drugs targeting the vascular endothelial growth factor pathway by the epigenetic silencing of FLT1 in renal cancer cells.Vascular-targeted therapies for Duchenne muscular dystrophyPlacental growth factor attenuates suppression of erythroid colony formation by interferonProinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention.Blocking the interaction of vascular endothelial growth factor receptors with their ligands and their effector signaling as a novel therapeutic target for cancer: time for a new look?The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge.Short peptides interfering with signaling pathways as new therapeutic tools for cancer treatment.FLT1 kinase is a mediator of radioresistance and survival in head and neck squamous cell carcinoma.An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancer.Hypoxia activates placental growth factor expression in lymphatic endothelial cells.Involvement of placental growth factor in Wallerian degeneration.Endothelin-1 increases the expression of VEGF-R1/Flt-1 receptors in rat cultured astrocytes through ETB receptors.Two-photon microscopy of a Flt1 peptide-hyaluronate conjugate.Suppression of neovascularization and experimental arthritis by D-form of anti-flt-1 peptide conjugated with mini-PEG(™).Tc-99m and Fluorescence-Labeled Anti-Flt1 Peptide as a Multimodal Tumor Imaging Agent Targeting Vascular Endothelial Growth Factor-Receptor 1
P2860
Q27330448-8F03D8AD-B79D-4868-A28D-2CFA5511393FQ30579979-1C9B692A-7B29-4AF4-9B18-CA9716097234Q31159383-DACD1080-9069-468F-99FD-1648412F6857Q33376945-10ECFE89-8776-4113-AE03-1F51A03753B6Q33518333-441FEBCA-256D-4D8C-AC1A-B5E0DD184DBDQ34187595-0E60BA30-3FD6-4133-9FB8-4A0B302AEA95Q34479948-BD2E9F33-4393-406D-8071-9B6891AF47FAQ35021476-31724E9C-D33C-41F8-866D-B0AA968536C5Q35083219-BC8F0CB7-601A-432B-96C8-A8EA53E0A8F8Q35176443-897E8FF0-6238-4656-8205-52E2968542D2Q35314659-04D231E7-8120-49E0-93BB-3E9AC980FB5DQ35394378-57FB04B2-EE29-402F-89BB-BD646B5C0D6CQ35474223-E8A5EBED-31F2-4D86-8F08-E47893EB263AQ35600456-9DB16419-6457-4DF2-801E-5535F110E87FQ36067203-9F4E67E2-B3DA-4852-8BB1-8313A9A7A3EFQ36835180-F32352D3-1041-4965-8B26-EE2ADC1FF719Q37019811-E14F0F92-1796-44CC-B3A0-ECBEED03CCE9Q37395327-C1F9E8F8-D763-4694-B630-050A4817273AQ37921797-830B0375-826A-439B-A09D-8DBDD0EC8B21Q38101684-93E879B6-6B1D-4092-BCB0-3B8010109A06Q38767147-DCA27143-FE87-4C8A-A10E-9EF2BFCF52E8Q39095142-7A4DC64E-6C78-4242-A876-C6E32A1759E3Q40298219-2A92ED20-FFA7-4649-8BD3-93AE97592687Q42212661-2D1E9CC5-39B2-45DB-8A70-97CF46E4C0F1Q44891928-192E1FA4-91DC-4F04-A011-9D1AD279DDE9Q48766549-C4514DAD-8427-48B1-AB19-6A4C38BB2B89Q51827148-32F9B5E1-E4E1-419F-A0ED-1917FBAC79C9Q54574739-B781248F-4FE1-41BC-997F-0596ECCFC99BQ57820483-03099199-6856-43BA-BB15-2BEAF76BAE61
P2860
Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Anti-flt1 peptide, a vascular ...... s tumor growth and metastasis.
@ast
Anti-flt1 peptide, a vascular ...... s tumor growth and metastasis.
@en
type
label
Anti-flt1 peptide, a vascular ...... s tumor growth and metastasis.
@ast
Anti-flt1 peptide, a vascular ...... s tumor growth and metastasis.
@en
prefLabel
Anti-flt1 peptide, a vascular ...... s tumor growth and metastasis.
@ast
Anti-flt1 peptide, a vascular ...... s tumor growth and metastasis.
@en
P2093
P1476
Anti-flt1 peptide, a vascular ...... s tumor growth and metastasis.
@en
P2093
Chi-Bom Chae
Dong-Goo Bae
Tae-Dong Kim
Wan-Hee Yoon
P304
P356
10.1158/1078-0432.CCR-04-1564
P407
P577
2005-04-01T00:00:00Z